Clifford Swan Investment Counsel LLC Trims Stock Position in Corteva, Inc. $CTVA

Clifford Swan Investment Counsel LLC cut its position in shares of Corteva, Inc. (NYSE:CTVA) by 3.8% during the fourth quarter, Holdings Channel.com reports. The firm owned 498,309 shares of the company’s stock after selling 19,450 shares during the quarter. Corteva makes up approximately 1.1% of Clifford Swan Investment Counsel LLC’s portfolio, making the stock its 23rd biggest position. Clifford Swan Investment Counsel LLC’s holdings in Corteva were worth $33,402,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also made changes to their positions in CTVA. Norges Bank purchased a new stake in shares of Corteva in the 4th quarter valued at approximately $504,001,000. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Corteva by 6,527.4% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock valued at $211,025,000 after purchasing an additional 3,100,709 shares in the last quarter. Perpetual Ltd grew its holdings in shares of Corteva by 78,688.5% in the fourth quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock valued at $175,336,000 after purchasing an additional 2,612,459 shares in the last quarter. Amundi grew its holdings in shares of Corteva by 125.3% in the third quarter. Amundi now owns 3,415,554 shares of the company’s stock valued at $219,620,000 after purchasing an additional 1,899,248 shares in the last quarter. Finally, Squarepoint Ops LLC grew its holdings in shares of Corteva by 423.6% in the third quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company’s stock valued at $117,550,000 after purchasing an additional 1,406,199 shares in the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Oppenheimer lifted their price objective on shares of Corteva from $86.00 to $89.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. JPMorgan Chase & Co. cut shares of Corteva from an “overweight” rating to a “neutral” rating and lifted their price objective for the company from $75.00 to $77.00 in a report on Thursday, February 5th. Wells Fargo & Company lifted their price objective on shares of Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a report on Tuesday, April 21st. Wolfe Research lifted their price objective on shares of Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Finally, Rothschild & Co Redburn boosted their price target on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $88.67.

Corteva Trading Down 0.4%

Shares of Corteva stock opened at $77.49 on Friday. The company has a fifty day simple moving average of $81.27 and a 200-day simple moving average of $74.92. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $85.63. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The stock has a market cap of $51.82 billion, a price-to-earnings ratio of 45.58, a PEG ratio of 2.38 and a beta of 0.57.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same quarter in the prior year, the business posted $1.13 EPS. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts forecast that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be given a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio is 42.35%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.